Neurology · 2011 · 181 citations · 31 references
This study provides Class II evidence that EZG(RTG) 1,200 mg/day is effective as adjunctive therapy in adults with partial-onset seizures with or without secondary generalization.
31
Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium Channels
Alan D. Wickenden, Weifeng Yu, Anrou Zou et al. · Molecular Pharmacology · 2000 · 318 citations